We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
+18.03%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$271M
AUM Growth
+$85.9M
Cap. Flow
+$61M
Cap. Flow %
22.49%
Top 10 Hldgs %
30.66%
Holding
68
New
20
Increased
25
Reduced
11
Closed
9

Top Buys

Rank Stock Value
1
NVO
Novo Nordisk
NVO
+$6.64M
2
ALXN
Alexion Pharmaceuticals
ALXN
+$5.6M
3
SNY icon
Sanofi
SNY
+$5.57M
4
CELG
Celgene Corp
CELG
+$5.25M
5
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$3.72M

Top Sells

Rank Stock Value
1
CI icon
Cigna
CI
+$7.6M
2
UNH icon
UnitedHealth
UNH
+$6.97M
3
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$5.38M
4
ZBH icon
Zimmer Biomet
ZBH
+$2.07M
5
ISRG icon
Intuitive Surgical
ISRG
+$1.87M

Sector Composition

Rank Sector Weight
1 Healthcare 92.84%
2 Energy 1.43%
3 Utilities 0.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GWPH
26
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$5.06M 1.86%
30,000
+25,000
+500% +$3.72M
WMGI
27
DELISTED
Wright Medical Group Inc
WMGI
$5.03M 1.85%
160,000
+12,199
+8% +$370K
BHC icon
28
Bausch Health
BHC
$2.31B
$4.94M 1.82%
200,000
+50,000
+33% +$1.19M
SNN icon
29
Smith & Nephew
SNN
$12.4B
$4.41M 1.63%
110,000
+34,000
+45% +$1.31M
VTRS icon
30
Viatris
VTRS
$18.7B
$4.25M 1.57%
150,000
+93,814
+167% +$2.74M
CNC icon
31
Centene
CNC
$33.1B
$4.25M 1.57%
80,000
+21,100
+36% +$1.28M
BMRN icon
32
BioMarin Pharmaceuticals
BMRN
$13.7B
$4M 1.47%
45,000
-10,000
-18% -$927K
ILMN icon
33
Illumina
ILMN
$28.8B
$3.88M 1.43%
12,850
-2,570
-17% -$749K
LHCG
34
DELISTED
LHC Group LLC
LHCG
$3.88M 1.43%
35,000
-5,000
-13% -$534K
LH icon
35
Labcorp
LH
$26B
$3.83M 1.41%
+29,100
New +$3.58M
A icon
36
Agilent Technologies
A
$42B
$3.62M 1.33%
45,000
-2,148
-5% -$163K
BIIB icon
37
Biogen
BIIB
$30.6B
$3.55M 1.31%
15,000
-5,000
-25% -$1.57M
ABBV icon
38
AbbVie
ABBV
$439B
$3.42M 1.26%
+42,500
New +$3.48M
TEVA icon
39
Teva Pharmaceuticals
TEVA
$42.8B
$3.37M 1.24%
215,000
+30,000
+16% +$529K
QGEN icon
40
Qiagen
QGEN
$8.88B
$3.25M 1.2%
75,444
-29,047
-28% -$1.17M
NVRO
41
DELISTED
NEVRO CORP.
NVRO
$3.13M 1.15%
+50,000
New +$2.35M
CHRS icon
42
Coherus Oncology
CHRS
$184M
$3.07M 1.13%
+225,000
New +$3M
EW icon
43
Edwards Lifesciences
EW
$53.5B
$3.06M 1.13%
+48,000
New +$2.74M
BLUE
44
DELISTED
bluebird bio
BLUE
$2.79M 1.03%
+1,367
New +$2.41M
XRAY icon
45
Dentsply Sirona
XRAY
$2.26B
$2.73M 1%
+55,000
New +$2.42M
VAR
46
DELISTED
Varian Medical Systems, Inc.
VAR
$2.69M 0.99%
+19,000
New +$2.5M
AMED
47
DELISTED
Amedisys
AMED
$2.46M 0.91%
20,000
– –
FMS icon
48
Fresenius Medical Care
FMS
$12.6B
$2.03M 0.75%
+50,000
New +$1.86M
BPMC
49
DELISTED
Blueprint Medicines
BPMC
$2M 0.74%
+25,000
New +$1.85M
PRGO icon
50
Perrigo
PRGO
$1.71B
$1.93M 0.71%
+40,000
New +$1.87M
1
2
3

Similar funds

AFP
ATX Financial Planning Austin, Texas $132M AUM
TCPW
Twin City Private Wealth Winston-Salem, North Carolina $132M AUM 11.31% 1-Year Est. Return
PCGDR
Pangea Capital Gestao de Recursos Rio De Janeiro $131M AUM
ACM
Alcosta Capital Management San Ramon, California $131M AUM 34.7% 1-Year Est. Return
9C
9823 Capital Dallas, Texas $132M AUM
STFP
Signal Tree Financial Partners Copley, Ohio $132M AUM 15.43% 1-Year Est. Return
ADEF
ABS Direct Equity Fund Stamford, Connecticut $131M AUM 7.53% 1-Year Est. Return
AC
Aldebaran Capital Carmel, Indiana $131M AUM 34.7% 1-Year Est. Return

Sivik Global Healthcare's Q1 2019 Portfolio in Review

As of Q1 2019, Sivik Global Healthcare held 68 positions worth $271M, up 46% from $186M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Sivik Global Healthcare deployed $61M of net new capital in Q1 2019, opening 20 new positions and adding to 25 existing holdings. Its largest new stake was Novo Nordisk: 270,000 shares worth $7.06M.

By sector, the portfolio is most concentrated in Healthcare at 93% of assets, up from 91% a quarter earlier, followed by Energy and Utilities.

On the sell side, the largest reduction was Intuitive Surgical, an estimated $1.87M trimmed.

  • Sivik Global Healthcare's largest Q1 2019 buy was Novo Nordisk: 270,000 shares worth $7.06M.
  • Sivik Global Healthcare added most to GW Pharmaceuticals Plc American Depositary Shares in Q1 2019, an estimated $3.72M increase.
  • Sivik Global Healthcare's biggest Q1 2019 reduction was Intuitive Surgical, cutting an estimated $1.87M.
  • Sivik Global Healthcare fully exited Cigna in Q1 2019, selling an estimated $7.6M.
  • Sivik Global Healthcare's ten largest holdings make up 31% of its $271M portfolio in Q1 2019.
  • Sivik Global Healthcare opened 20 new positions and closed 9 in Q1 2019.
  • Sivik Global Healthcare's portfolio value rose 46% quarter-over-quarter to $271M.

Based on Sivik Global Healthcare's 13F filing for Q1 2019, filed 8 May 2019.